CDKN2A and metastatic melanoma: For instance, gene silencing via hypermethylation of the cyclin-dependent kinase inhibitor 2A gene (CDKN2A), a well-known cell- cycle regulator, is described in 19 %-of primary and 33 % of metastatic melanomas [25].